2881 (2881) Fair Value & Analysis

Basic Materials · Market cap HK$1.1B

2 2881 2881 · HK

PriceHK$11.67

Fair ValueHK$11.72

Upside+0.4%

Quality52/100

Watch 2881 for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range HK$8.20 – HK$15.23

Fair value as of: Jul 2, 2026

From 14 valuation models · updated today

Share price +16.8% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$4.63 – HK$12.70 · fair‑value band HK$8.20 – HK$15.23 · the HK$11.67 price screens below the HK$11.72 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

2881 (2881) currently trades at HK$11.67, while our model-based Fair Value estimate is HK$11.72 — implying the stock looks roughly 0.4% undervalued today. We read business quality at 52/100 (solid quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, 2881 generated revenue of HK$2.7B at a net margin of 2.4%. Revenue declined 25.5% year over year. It earns a return on equity of 9.2%. Net debt stands at HK$1.3B. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$2.7B

Revenue growth (YoY) -25.5%

Net margin 2.4%

Return on equity 9.2%

Free cash flow −HK$295M FY2025

P/E ratio 15.0

More key figures

Operating margin 2.5%

Dividend yield 2.8%

EPS growth (YoY) -68.3%

Net debt HK$1.3B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

2881 reported revenue of HK$2.7B in FY2025 versus HK$2.8B in FY2021, a compound −1.2%/yr. Reported net income was HK$62.5M in FY2025, compounding −33.0%/yr from FY2021.

Revenue −1.2%/yr

FY21 HK$2.8B

FY22 HK$3.1B

FY23 HK$2.7B

FY24 HK$3.3B

FY25 HK$2.7B

Net income −33.0%/yr

FY21 HK$309M

FY22 HK$338M

FY23 HK$72.6M

FY24 HK$123M

FY25 HK$62.5M

Is 2881 fairly valued? → Check now

Similar stocks

6 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Linde plc LIN	€425.60	€106.89	-75%
Shin-Etsu Chemical Co SHECY	$22.62	$12.94	-43%
BASF SE BAS	€47.98	€23.76	-50%
Ningxia Baofeng Energy Group 600989	¥23.43	¥34.39	+47%
Dow Inc D1OW34	R$41.12	R$16.66	-59%
Ganfeng Lithium Group 002460	¥67.60	¥22.08	-67%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 2881 (2881) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$11.72 versus a price of HK$11.67 — about +0% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 2881?

Our model-based fair value for 2881 is HK$11.72 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$11.67.

What is the quality score of 2881?

2881 has a Quality Score of 52/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 2881 (2881)?

2881 reported trailing-twelve-month revenue of about HK$2.7B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 2881?

The net profit margin of 2881 is about 2.4%, meaning it keeps roughly 2.4% of revenue as net income. Based on the latest reported figures.

Does 2881 pay a dividend?

2881 currently shows a dividend yield of about 2.76% relative to its recent price (as of Jul 2, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.